170823 ⎘
Detection or diagnosis of diseases; Ophthalmology Retinal disorders, e.g. retinopathy
METHODS FOR MONITORING MOLECULAR BIOMARKERS FOR AGING AND DISEASE
#2RELATIVE POTENCY ASSAY FOR VIRAL VECTOR ENCODING ISOMEROHYDROLASES
#3PROBES AND METHODS FOR TARGETED VISUALIZATION OF NLRP3 INFLAMMASOMES
#4Blood Biomarkers and Diagnostic Methods for Small Vessel Diseases
#5BIOMARKERS AND THEIR USE IN DIAGNOSING PARKINSON'S DISEASE, VITREORETINAL DISEASES, AND AGE-RELATED PATHOLOGIES
#6BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING DISEASES OF THE EYE
#7RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal Transition
#8COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#9ASSAYS FOR POTENCY OF HUMAN RETINAL PIGMENT EPITHELIUM (RPE) CELLS AND PHOTORECEPTOR PROGENITORS
#10FFA1 (GPR40) AS A THERAPEUTIC TARGET FOR NEURAL ANGIOGENESIS DISEASES OR DISORDERS
#11PROCESSING FUNDUS IMAGES USING MACHINE LEARNING MODELS
#12STIMULATION OF THE HEALING PROCESS ON THE RETINAL PIGMENT EPITHELIUM AFTER R:GEN WITH RTF TECHNOLOGY
#13Blood biomarkers and diagnostic methods for small vessel diseases
#14Assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors
#15METABOLIC RESCUE OF RETINAL DEGENERATION
#16OPTIDICER CONSTRUCT FOR AGE-RELATED MACULAR DEGENERATION
#17ASSAY FOR RAPID EVALUATION OF CHOROIDAL MAST CELL DEGRANULATION
#18PREDICTION OF THE CONTENT OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE RETINA BY MEASURING 7 CHOLESTEROL ESTER MOLECULES
#19Predictive Markers Useful in the Treatment of Wet Age-Related Macular Degeneration
#20Biomarkers useful in the treatment of subjects having diseases of the eye
#21A COMBINATION OF BIOMARKERS FOR DIAGNOSING OF DIABETIC RETINOPATHY AND USE THEREOF
#22A COMBINATION OF BIOMARKERS FOR DIAGNOSING OF AGE-RELATED MACULAR DEGENERATION AND USE THEREOF
#23INTEGRIN ALPHA V BETA 3 TARGETING PROBE FOR DIAGNOSING RETINOCHOROIDAL NEOVASCULAR DISEASES AND PREPARATION METHOD THEREFOR
#24BIOMARKERS FOR DIAGNOSIS OF OCULAR DISEASES AND THE METHOD THEREOF
#25RELATIVE POTENCY ASSAY FOR VIRAL VECTOR ENCODING ISOMEROHYDROLASES
#26FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders
#27STEM CELL-DERIVED CELL CULTURES, STEM CELL-DERIVED THREE DIMENSIONAL TISSUE PRODUCTS, AND METHODS OF MAKING AND USING THE SAME
#28ASSAY FOR THE DIAGNOSIS OF MACULAR DEGENERATION
#29Processing fundus images using machine learning models
#30METHODS OF PREDICTING THE DEVELOPMENT OF AMD BASED ON CHROMOSOME 1 AND CHROMOSOME10
#31Mutations in rhodopsin gene in zebrafish and uses thereof
#32Detection of high risk drusen
#33RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
#34Quantitation of Free and Total N-Acetylcysteine Amide and Its Metabolite N-Acetylcysteine in Human Plasma Using Derivatization and Electrospray LC-MS/MS
#35Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#36BIOMARKER FOR ANTI-TNF THERAPY IN RETINAL DISEASES
#37Biosensor and application of the same
#38BLOOD BIOMARKERS AND DIAGNOSTIC METHODS FOR SMALL VESSEL DISEASES
#39Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization
#40Processing fundus images using machine learning models
#41Method for producing retinal tissue
#42Predictive markers useful in the treatment of wet age-related macular degeneration
#43COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#44Mutations in rhodopsin gene in zebrafish and uses thereof
#45Diagnostics and Therapeutics for Macular Degeneration-Related Disorders
#46Endoglin Antibodies
#47Method for determination and identification of cell signatures and cell markers
#48ASSAY FOR THE DIAGNOSIS OF MACULAR DEGENERATION
#49COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS
#50Assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors
#51Methods of use for intermediate filament protein probes
#52Smart contact lenses and smart glasses
#53Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#54Biomarkers useful in the treatment of subjects having diseases of the eye
#55ASSAY SYSTEMS FOR POINT OF CARE DETECTION OF OCULAR ANALYTES
#56BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING RETINITS PIGMENTOSA
#57Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions
#58Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide
#59Endoglin antibodies
#60Compositions and methods for treatment of diabetic retinopathy
#61BIOMARKERS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION
#62Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis
#63Marker for diagnosing diabetic retinopathy and use thereof
#64Endoglin antibodies
#65Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#66Methods of diagnosing, treating and monitoring diabetic retinopathy
#67Azapeptides as CD36 binding compounds
#68Therapeutic or prophylactic agent for retinopathy of prematurity, testing method for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity
#69Predicting and treating diabetic complications
#70Azapeptides as CD36 binding compounds
#71METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES
#72Endoglin antibodies
#73METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF GENETIC AND RETINAL DISEASE
#74COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF MITOCHONDRIAL DISEASES
#75MODULATORS OF RETINOL-RETINOL BINDING PROTEIN (RBP)-TRANSTHYRETIN (TTR) COMPLEX FORMATION
#76METHODS FOR MODULATING MACROPHAGE PROLIFERATION IN OCULAR DISEASE USING POLYAMINE ANALOGS
#77METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES
#78METHOD AND APPARATUS FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION
#79FUNCTIONALIZED ORGANOTYPIC SYSTEMS
#80Methods and Compounds for Promoting Vessel Regression
#81Complement assays and uses thereof
#82Variants in complement regulatory genes predict age-related macular degeneration
#83Method of using CCR3 binding agents to detect choroidal neovascularization
#84MARKERS RELATED TO AGE-RELATED MACULAR DEGENERATION AND USES THEREFOR
#85Polypeptides for Specific Targeting to Otx2 Target Cells
#86Compositions and methods for treatment of angiogenesis-associated ocular disorders
#87METHODS AND COMPOSITIONS FOR TREATING OPTHALMIC CONDITIONS WITH RETINOL DERIVATIVES
#88BIO-MARKERS FOR DIAGNOSING DIABETIC RETINOPATHY
#89CCR3 inhibition for ocular angiogenesis and macular degeneration
#90Compositions and methods for inhibiting vascular permeability
#91Biomarkers of inflammation in Bruch's membrane of the human retina
#92Phenotype-Genotype Relationship in Age-Related Macular Degeneration
#93Diagnostics and Therapeutics for Macular Degeneration-Related Disorders
#94Methods and Compounds for Promoting Vessel Regression
#95HEMOGLOBIN-BASED METHODS FOR PROPHYLAXIS, DIAGNOSIS AND/OR TREATMENT OF RETINAL DISORDERS
#96Method of treating CD40-mediated diseases
#97Methods and Compositions For Diagnosis of Age-Related Macular Degeneration
#98Endoglin antibodies
#99DOMAIN ANTIBODY CONSTRUCT
#100Methods of Screening for Anti-Angiogenic Compounds
#101Humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration
#102Method and apparatus for diagnosing age-related macular degeneration
#103Methods and compositions for treating ophthalmic conditions with retinyl derivatives
#104BIOMARKERS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION
#105DIAGNOSIS OF AGE-RELATED MACULAR DEGENERATION USING BIOMARKERS
#106Azapeptides as CD36 binding compounds
#107Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress
#108METHOD OF MONITORING RETINOPATHY
#109Compositions and methods for treating ocular pathologic angiogenesis and vascular permeability
#110Agent detection and/or quantitation in a biological fluid
#111Factor H polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration
#112Use of Crystallin For The Modulation of Angiogenesis
#113Protection against and treatment of age related macular degeneration
#114METHODS FOR TREATING PATHOLOGICAL NEOVASCULARIZATION
#115Phenotype-Genotype Relationship in Age-Related Macular Degeneration
#116Methods of identifying neuroprotective compounds for retinal ganglion cells
#117Method for identifying diabetic patients at increased risk for pathological complications
#118Bio-Markers For Diagnosing Diabetic Retinopathy
#119Compositions and methods for treatment of diabetic retinopathy
#120CCR3 inhibition for ocular angiogenesis and macular degeneration
#121COMPOSITIONS AND METHODS FOR TREATING DIABETIC EYE DISEASE
#122COMPOSITION FOR ANALYZING DIABETES MELLITUS AND/OR RETINAL VASCULAR DISEASE AND ANALYZING METHOD THEREOF
#123Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation
#124HEMOGLOBIN-BASED METHODS FOR PROPHYLAXIS, DIAGNOSIS AND/OR TREATMENT OF RETINAL DISORDERS
#125Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions
#126Novel Integrin Ligand ITGL-TSP
#127Biomarkers Associated With Age-Related Macular Degeneration
#128Quantitative Evaluation and Image Analysis of Choroidal Neovascular Membrane and Other Retinal and Subretinal Lesions
#129Pigment epithelium-derived factor as a therapeutic agent for vascular leakage
#130Diagnostics and therapeutics for macular degeneration
#131Variants in complement regulatory genes predict age-related macular degeneration
#132Revascularization of Ischemic Retinal Tissue and Screening Method Therefor
#133Diagnostics and therapeutics for macular degeneration-related disorders
#134DIAGNOSTICS AND THERAPEUTICS FOR ARTERIAL WALL DISRUPTIVE DISORDERS
#135Diagnostics and therapeutics for ocular disorders
#136Ocular fluid markers
#137Domain antibody construct
#138Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
#139Transgenic mice carrying the HP-2 gene and uses as models for vascular diseases
#140Novel Integrin Ligand ITGL-TSP
#141Novel Integrin Ligand ITGL-TSP
#142Lectin binding to choroidal neovascularization
#143Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it
#144Diagnostics and therapeutics for macular degeneration-related disorders
#145Protein for diagnosing diabetic retinopathy
#146Methods and compounds for promoting vessel regression
#147Methods and compositions for treating ophthalmic conditions with retinyl derivatives
#148Methods, assays and compositions for treating retinol-related diseases
#149Detection and analysis of ophthalmically-relevant fluorescent molecules
#150Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation
#151Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration
#152Diagnostics and therapeutics for macular degeneration-related disorders
#153Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
#154Novel integrin ligand ITGL-TSP
#155Diagnostics and therapeutics for arterial wall disruptive disorders